scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023336379 |
P356 | DOI | 10.2165/11206000-000000000-00000 |
P698 | PubMed publication ID | 21043546 |
P50 | author | Lesley J Scott | Q62563724 |
P2860 | cites work | Epidemiology of pertussis | Q36118044 |
Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations | Q36118110 | ||
Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination | Q36148322 | ||
Economic considerations for pertussis booster vaccination in adolescents | Q36148334 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | teenager | Q1492760 |
immunization | Q1415366 | ||
P304 | page(s) | 387-406 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | BioDrugs | Q4914612 |
P1476 | title | Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults | |
P478 | volume | 24 |
Q36849826 | Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries |
Q34636630 | Pertussis re-emergence in the post-vaccination era |
Q83477433 | Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults |
Search more.